Exploratory pharmacokinetic and preliminary efficacy modelling of select orally administered antiviral compounds following DehydraTECH formulation enhancement

Researchers around the world are racing to find treatment solutions to combat COVID-19, the disease cause by infection of the novel coronavirus (SARS-CoV-2). The use of antiretroviral therapy has recently shown preliminary promise. However, a barrier relates to bioavailability challenges, i.e., poor uptake, of these drugs. Poor bioavailability limits drug utility which could be paramount […]

Read More